Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old

Clinical trial NCT06769633 · RECRUITING

Trial details

NCT number: NCT06769633
Sponsor: Italfarmaco
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2025-01-02
Primary completion: 2029-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.